The Christie charity Impact Report 2021-22

BUILDING RESEARCH AND INNOVATION Another new building project which took major strides forward this year was our new research facility, currently known as the Paterson redevelopment project, which is on schedule to open in 2023.

It will be a purpose-built biomedical cancer research facility bringing together three powerhouses of innovation – The Christie, The University of Manchester and Cancer Research UK. The new facility will become home to several hundred scientists, doctors, nurses and support staff who will be at the heart of our ambition to lead the world in clinical trial recruitment, supporting the development of new and kinder cancer therapies. It will double the number of cancer patients taking part in clinical trials by 2030.

Our research and innovation team operates more than 650 clinical trials at any one time and is one of the biggest cancer clinical trials centres in Europe. Through our National Institute for Health Research (NIHR) Manchester Clinical Research Facility at The Christie, staff and patients benefit from a large, dedicated clinical research environment where patients can participate in complex and early phase clinical trials, many of which are supported by our charity. We continue to fundraise for this vital facility and as ever remain grateful for any support received. Donations can continue to be made via our website here.

650

Our research and innovation team operates more than 650 clinical trials at any one time

35